1295 Systems biology analysis of anti-tumor immunity M Nikmaneshi, J Baish, T Padera, L Munn Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
577 Cancer immunotherapy responses persist after lymph node resection H Zhou, MJ O’Melia, JW Baish, LB Darragh, P Lei, L Menzel, JJ Rajotte, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
7. Methicillin-resistant Staphylococcus aureus pathogenicity causes sustained lymphatic dysfunction D Jones, EFJ Meijer, C Blatter, S Liao, E Pereira, E Bouta, K Jung, ... Imaging Lymphatics, 106, 2017 | | 2017 |
897-F Wnt inhibition improves efficacy of immune checkpoint blockade in glioblastoma S Krishnan, S Lee, Z Amoozgar, S Subudhi, AS Kumar, J Posada, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 2), 2023 | | 2023 |
A mathematical framework for predicting oxygen transport and vessel remodeling in tumors LL Munn, W Kamoun, JA Tyrrell The FASEB Journal 24, 750.3-750.3, 2010 | | 2010 |
A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy BR Stoll, C Migliorini, A Kadambi, LL Munn, RK Jain Blood 102 (7), 2555-2561, 2003 | 159 | 2003 |
A mechanobiological mathematical model of liver metabolism MR Nikmaneshi, B Firoozabadi, LL Munn Biotechnology and Bioengineering 117 (9), 2861-2874, 2020 | 6 | 2020 |
A model for the kinetics of homotypic cellular aggregation under static conditions S Neelamegham, LL Munn, K Zygourakis Biophysical journal 72 (1), 51-64, 1997 | 37 | 1997 |
A multi-scale model for determining the effects of pathophysiology and metabolic disorders on tumor growth MR Nikmaneshi, B Firoozabadi, A Mozafari, LL Munn Scientific reports 10 (1), 3025, 2020 | 16 | 2020 |
A Multiresolution Approach with Method-Informed Statistical Analysis for Quantifying Lymphatic Pumping Dynamics MS Razavi, KJ Ruscic, EG Korn, M Marquez, TT Houle, D Singhal, ... bioRxiv, 2024.04. 24.590950, 2024 | | 2024 |
A protocol for phenotypic detection and characterization of vascular cells of different origins in a lung neovascularization model in rodents RC Jones, DE Capen, KS Cohen, LL Munn, RK Jain, DG Duda Nature protocols 3 (3), 388-397, 2008 | 30 | 2008 |
A Self-Assembly Method for Creating Vascularized Tumor Explants Using Biomaterials for 3D Culture LL Munn, D Bazou Cancer Cell Culture: Methods and Protocols, 211-220, 2023 | | 2023 |
A Study of High–Versus Low-Dose-Bevacizumab in Combination with Local Radiotherapy and 5-Flourouracil Chemotherapy in a Phase I Trial for Patients with Locally Advanced Rectal … CG Willett, Y Boucher, DG Duda, E di Tomaso, LL Munn, RT Tong, L Petit, ... | | |
Aberrant vascular architecture in tumors and its importance in drug-based therapies LL Munn Drug discovery today 8 (9), 396-403, 2003 | 153 | 2003 |
Abstract A04: Distant lymphoid organs compensate for ICB efficacy after TDLN dissection H Zhou, M O'Melia, P Lei, JJ Rajotte, MR Razavi, J Baish, LL Munn, ... Cancer Immunology Research 10 (12_Supplement), A04-A04, 2022 | | 2022 |
Abstract A64: Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2 C Voutouri, CC Hardin, V Naranbhai, MR Nikmaneshi, MJ Khandekar, ... Cancer Immunology Research 10 (12_Supplement), A64-A64, 2022 | | 2022 |
Abstract B39: Modulation of cancer immunotherapy by the microbiome: Insights from computational analyses of preclinical studies C Harkos, A Hadjigeorgiou, AK Mishra, G Morad, S Johnson, NJ Ajami, ... Cancer Immunology Research 10 (12_Supplement), B39-B39, 2022 | | 2022 |
Abstract LB-347: Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival J Kloepper, L Riedemann, Z Amoozgar, G Seano, KH Susek, V Yu, ... Cancer Research 76 (14_Supplement), LB-347-LB-347, 2016 | | 2016 |
Abstract LB-348: Evolution of physical forces in the tumor microenvironment and implications for therapeutic resistance. T Stylianopoulos, JD Martin, S Jain, M Snuderl, VP Chauhan, LL Munn, ... Cancer Research 73 (8_Supplement), LB-348-LB-348, 2013 | | 2013 |
Abstract LB-363: Inhibition of placental growth factor (PlGF) leads to regression of medulloblastoma M Snuderl, ND Kirkpatrick, EC Walsh, E Chung, WS Kamoun, ... Cancer Research 70 (8_Supplement), LB-363-LB-363, 2010 | | 2010 |